
CP-226269
CAS No. 220941-93-5
CP-226269 ( —— )
产品货号. M34212 CAS No. 220941-93-5
CP 226269 是一种有效的多巴胺 D4 受体 (dopamine D4 receptor) 激动剂,可以诱导钙通量,其 EC50 值为32.0 nM。CP 226269 可用于精神分裂症等相关疾病的研究。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1266 | 有现货 |
![]() ![]() |
5MG | ¥1978 | 有现货 |
![]() ![]() |
10MG | ¥2899 | 有现货 |
![]() ![]() |
25MG | ¥4528 | 有现货 |
![]() ![]() |
50MG | ¥6436 | 有现货 |
![]() ![]() |
100MG | ¥8568 | 有现货 |
![]() ![]() |
500MG | ¥17060 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CP-226269
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CP 226269 是一种有效的多巴胺 D4 受体 (dopamine D4 receptor) 激动剂,可以诱导钙通量,其 EC50 值为32.0 nM。CP 226269 可用于精神分裂症等相关疾病的研究。
-
产品描述CP 226269 is a potent dopamine D4 receptor agonist that induces calcium flux with EC50 of 32.0 nM. CP 226269 can be used in the research of schizophrenia and other related diseases.
-
体外实验——
-
体内实验——
-
同义词——
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体Dopamine Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number220941-93-5
-
分子量310.37
-
分子式C18H19FN4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(C=1NC=2C(C1)=CC(F)=CC2)N3CCN(CC3)C4=CC=CC=N4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Robert B Moreland, et al. Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5). Biochem Pharmacol. 2004 Aug 15;68(4):761-72.??
产品手册




关联产品
-
Seridopidine
Seridopidine (ACR343) is a modulator of dopaminergic activity that is used as an oral therapy for schizophrenia, Parkinson's disease, and Tourette's syndrome.
-
Apomorphine hydrochl...
阿扑吗啡盐酸盐半水合物是一种非选择性多巴胺激动剂,可激活 D1 样和 D2 样受体。
-
Benperidol
Benperidol (Anquil) is a butanone analog with antipsychotic and stabilizing properties, and has been shown to be effective in blocking D2 receptors.Benperidol can be used in positron emission tomography (PET) scanning to measure D(2) dopamine receptor binding in vivo.Benperidol has been shown to be effective in blocking D2 receptors in vivo.Benperidol has been shown to be effective in blocking D2 receptors in vivo.